Print

Event Opportunity - Fireside Chat, Science to Business Network Vancouver-Victoria Chapter, Via Video Conference

March 23, 2022

S2BN Vancouver-Victoria Chapter: Women In Science - A Fireside Chat 

Event Summary

Join us for an insightful fireside chat with inspiring women-identifying scientists from diverse disciplines united by their history of conquering stigma and barriers faced by women and other minorities in STEM. Hear from these women about challenges they faced throughout their career and, more importantly, how they overcame them to stride towards success with grace and grit. Have the opportunity to ask your questions and determine how to navigate the current and future science landscape in Canada as a woman-identifying person.

Event objectives

  • Understand the unconscious and conscious biases and barriers against women and other minorities in STEM
  • Learn about challenges faced by successful women-identifying scientists in diverse disciplines and how they overcame them
  • Determine how to best set yourself up for success as a woman in STEM

Event Details

March 25th, 12 pm - 1 pm PST

Online (Zoom)

Register Here:

https://www.s2bn.org/events-dg2jf/vancouver-victoria-women-in-science-a-fireside-chat

Speaker Bios

Dr. Larissa Vingilis-Jaremko, Founder & President

Canadian Association for Girls in Science (CAGIS)

https://girlsinscience.ca/

In 1992, at age nine, Larissa Vingilis-Jaremko founded the Canadian Association for Girls in Science (CAGIS), a not-for-profit organization that supports interest in science, technology, trades, engineering, and mathematics (STEM) among girls and gender nonconforming youth. As a child, Larissa noticed that girls in her class had negative, stereotyped images of STEM professionals, stereotypes Larissa knew weren’t true because her parents, a scientist and engineer, didn’t fit the mould. She wanted to expose girls to diverse role models, exploration, and hands-on activities to break stereotypes and share the excitement of STEM.  What started as a small, local group of 20 girls expanded to a national organization with chapters across Canada.

Larissa remains president of CAGIS and has become a strong voice and recognized expert internationally. She is often consulted by various levels of government, speaks to the media regularly on issues relating to gender equity in STEM, and serves as an adviser and consultant on numerous selection and review committees.

Larissa has created awareness of the barriers that still exist, and through her efforts has become renowned for her work. She has received a variety of honours including Canada’s Top 100 Most Powerful Women, Toronto Young Woman of Distinction, London Young Woman of Excellence, Youth in Motion Top 20 Under 20, Chatelaine’s 80 Amazing Canadian Women to Watch, and more. In addition to her work with CAGIS, Larissa serves as chair of the board of directors of the Canadian Coalition of Women in Engineering, Science, Trades, and Technology (CCWESTT).  Larissa is trained as a vision scientist and received her PhD from McMaster University in 2013.

Dr. Edie Dullaghan, Scientific Director

adMare Academy, adMare BioInnovations

https://www.admarebio.com/

As the Scientific Director of the adMare Academy, Dr. Edie Dullaghan plays a direct role in the development and advancement of scientific talent within the Canadian life sciences ecosystem. At adMare, Dr. Dullaghan supports the Academy’s programs, including The BioInnovation Scientist Program, a one-of-a-kind program for early-career scientists looking to build a drug development and commercialization career in Canada’s life sciences industry.

Previously, Dr. Dullaghan worked at CDRD – The Centre for Drug Research and Development as the Director of Target Validation, where she spent over ten years advancing made-in-Canada innovations while also mentoring the next generation of drug developers. Prior to joining CDRD, Dr. Dullaghan served as the Pathogenomics Project Leader for Inimex Pharmaceuticals Inc., developing robust animal models of human infections with a focus toward host defense peptides and small molecules. Over the course of her career, she has managed several large-scale R&D programs, including leading a global collaboration with LifeArc and The Defence Science and Technology Laboratories (DSTL) in the United Kingdom using a novel approach in drug target discovery that capitalises on areas of commonality across pathogens.

Dr. Dullaghan obtained her PhD in the U.K. at the National Institute for Medical Research, studying the molecular genetics of the SOS response in Mycobacterium tuberculosis, the causative agent of TB.

Would you like to join our S2BN Vancouver-Victoria team?

Email us at: s2bnvancouver@s2bn.org